We report the case of a 41-year-old man who presented with progressive right-sided ear pressure, otalgia, hearing loss, tinnitus, and intermittent otorrhea. Computed tomography and magnetic resonance imaging detected a soft-tissue mass in the right mastoid with intracranial invasion and erosion through the tegmen tympani and mastoid cortex. Histopathologic examination was consistent with an infl ammatory pseudotumor (plasma cell granuloma). These lesions rarely occur in the temporal bone. When they do, they are locally destructive and can erode bone and soft tissues. Aggressive surgery is recommended as a fi rstline treatment, with adjunctive steroid or radiotherapy reserved for residual or refractory disease. Our patient subsequently experienced multiple recurrences, and his treatment required all of these modalities. At the most recent follow-up, he was disease-free and doing well.
Introduction
An infl ammatory pseudotumor is an unencapsulated, benign tumor of unclear etiology. It was fi rst described by Bahadori and Liebow in 1973 . 1 This uncommon infl ammatory lesion has also been referred to as a plasma cell granuloma, infl ammatory myofi broblastic pseudotumor, infl ammatory histiocytoma, and infl ammatory fi brosarcoma. It most commonly arises in the lungs, but it has been reported in nearly every soft-tissue structure of the body.
Infl ammatory pseudotumors of the head and neck are rare, accounting for fewer than 5% of all extrapulmonary cases. 2 In the head and neck, the most common location is the orbit, followed by the meninges, paranasal sinuses, infratemporal fossa, and soft tissues. The temporal bone, skull base, and facial nerve are very rarely involved. Indeed, our review of the literature revealed only 35 previous case reports of infl ammatory pseudotumor affecting the skull base and the temporal bone area (table 1) . The most common presenting symptoms of tumor growth resulting in local destruction of middle ear structures are otalgia, hearing loss, and otorrhea. Standard treatments include surgical excision, steroid therapy, and radiotherapy, depending on the size and location of the tumor, as well as the patient's age and comorbidities. 7, 24 In this article, we report a new case of infl ammatory pseudotumor of the temporal bone, and we review the literature on this rare fi nding.
Case report
A 41-year-old man of South Asian descent was referred to the senior author (R.W.J.) for evaluation of a 7-month history of right-sided ear pressure and pain, hearing loss, tinnitus, and intermittent drainage. The pain was sharp; it extended from the ear and mastoid area and radiated down the right side of the neck. The patient denied vertigo or imbalance, and his left ear was uninvolved.
The referring otolaryngologist had performed a right myringotomy 3 months earlier, and it had revealed the presence of a thick, cloudy fl uid that grew normal ear fl ora on culture. Postoperatively, the patient reported the onset of pulsatile tinnitus.
At the referral visit, the patient reported no history of other ear surgeries, relevant trauma, recurrent infections, or exposure to excessive noise. He did report that he had traveled to Hong Kong four times during the previous year. On physical examination, the external ears were normal bilaterally. An area of point tenderness was noted above the right pinna, and an erythematous, nonfl uctuant swelling was detected over the right mastoid and neck. The right external auditory canal was tender and exhibited signifi cant posterosuperior skin thickening, which obscured the right tympanic membrane; the tympanic membrane was opaque and thickened. The Weber test lateralized to the right, and the Rinne test was negative on the right; these fi ndings were consistent with a right-sided conductive hearing loss. However, audiometry demonstrated a mild highfrequency sensorineural hearing loss on the right with no conductive defi cit, and a type C right tympanogram suggested eustachian tube dysfunction. High-resolution computed tomography (CT) revealed that a soft-tissue mass had fi lled the right mastoid and focally eroded through the tegmen tympani and mastoid cortex. Contrast-enhanced magnetic resonance imaging (MRI) demonstrated a diffuse, homogeneous lesion in the right mastoid (fi gure 1).
The patient underwent a right canal-wall-up mastoidectomy with diagnostic and therapeutic intent. Surgical exposure revealed very adherent, fi brous, and rubbery vascular tissue that extended through multiple mastoid air cell tracts, including the mastoid tip, and eroded through the tegmen tympani and mastoid cortex, with invasion of the medial aspect of the temporalis muscle.
Intraoperative frozen-section analysis revealed "lymphoblastic infi ltrate." Therefore, the decision was made to end the procedure and to leave the residual tissue in the mastoid antrum in the event that the fi nal pathology report established a diagnosis of lymphoma. The fi nal pathologic diagnosis was "plasma cell granuloma." Histology of the lesion revealed fi broconnective tissue with a heavy cellular infi ltrate composed of predominantly mature plasma cells with Russell bodies (fi gure 2), a small number of lymphocytes with follicles, neutrophils, a few eosinophils, and fi brosis. Plasma cells were immunoreactive to kappa and lambda light chains, suggesting the polyclonal nature of the lesion. In situ hybridization for Epstein-Barr virus (EBV) was negative.
Prednisone at 60 mg/day followed by a taper was initiated for the treatment of the residual infl ammatory pseudotumor. However, after 1 week of therapy, the dose was reduced in response to complaints of hip and lower-extremity pain, symptoms that are associated with avascular necrosis. 25 One month postoperatively, the patient reported decreased pain and pressure, continued tinnitus, and no change in hearing. On physical examination, his right ear canal was noticeably more patent, and otoscopy revealed a thinner, translucent tympanic membrane with focal areas of neovascularization. 
Follow-up Treatment and outcome
Canal-wall-up Disease-free at last mastoidectomy for biopsy follow-up with postoperative steroids, then defi nitive excision via revision canal-wall-up mastoidectomy, temporal and middle fossa craniotomy, and duraplasty with postoperative steroids and radiotherapy Four months postoperatively, the patient reported that he had been feeling lethargic for the previous 3 weeks. A follow-up MRI detected an enhancing mass in the right temporal bone that extended into the dura of the middle cranial fossa, with no midline shift. This fi nding was consistent with a recurrence of the mass, and surgical excision was therefore deemed to be the best option. A right revision canal-wall-up mastoidectomy, a temporal and right middle cranial fossa craniotomy, and a duraplasty were performed. Pathology confi rmed that the mass represented a recurrence of the infl ammatory pseudotumor. Steroid therapy was instituted postoperatively.
Ten months following the second surgery, the patient returned complaining of weakness in his left hand and diffi culty speaking. Another MRI demonstrated a focal area of enhancement in the right parietal area with considerable vasogenic edema in the surrounding area. Given the absence of a mass, radiotherapy was administered at a dose of 4,500 cGy in 25 fractions over 36 days. At the most recent follow-up, he was disease-free and doing well.
Discussion
Infl ammatory pseudotumors usually demonstrate unusual clinical, radiographic, and pathologic features. In terms of etiology, infectious, autoimmune, and neoplastic processes have been proposed. Infections with EBV or human herpesvirus 8 have been implicated in infl ammatory pseudotumors of the spleen and liver. 7, 24 Because our patient reported frequent travel to Hong Kong, a region where EBV-associated neoplasms are more common, we examined his lesion for EBV DNA and found no evidence of EBV infection.
While our patient's complaints of otalgia, hearing loss, and otorrhea might suggest chronic otitis media or a cholesteatoma, he had a number of clinical and radiographic fi ndings suggestive of a neoplasm. Limited otoscopy revealed involvement of the external auditory canal, but no visible cholesteatoma, retraction pocket, or perforation was present. Audiometry showed no conductive hearing loss, as would be expected with a cholesteatoma or chronic otitis media. Moreover, the focal area of bone destruction noted laterally through the mastoid cortex was atypical for cholesteatoma. Instead, these fi ndings were consistent with those described in other reports of temporal bone infl ammatory pseudotumors, including homogeneous enhancement with contrast and areas of bony destruction along with areas of radiographic normality; also, dural enhancement has been described in many cases (table 2) . 7, 11 The absence of middle ear involvement both on CT and MRI suggested a neoplastic lesion rather than a cholesteatoma or mastoiditis. Temporal bone infl ammatory pseudotumors have been successfully treated with surgical excision, radiotherapy, and high-dose steroids, all of which we used in our patient. In view of the aggressive and unpredictable course of temporal bone infl ammatory pseudotumor, some authors believe that it warrants urgent evaluation with biopsy and defi nitive surgical therapy. 24 Because these tumors are unencapsulated, surgical excision with wide margins is necessary to prevent recurrence. A recurrence rate of 22% at 12 months following surgical excision has been reported. 24 Tumors that involve the facial nerve or skull base can make complete excision diffi cult in view of the poten- Figure 2 . On H&E staining, the biopsy specimen exhibits dense fi broconnective tissue with heavy lymphoplasmacytic cellular infi ltrate composed of mature plasma cells and lymphocytes with follicles, but few eosinophils and neutrophils. Occasional Russell bodies are seen. Coulson et al, 21 2008 Complete opacifi cation of the middle ear cleft, Abnormally enhancing soft-tissue mass in attic, and mastoid cells; destruction of the the right external auditory canal, middle ear, septae between the mastoid cells, but no attic, and mastoid air cells; diffuse involveerosive changes of the tegmen tympani, ment of the temporal and parietal brain jugular bulb, or lateral semicircular canal parenchyma with contrast enhancement, extending through the skull base, into the infratemporal fossa, and medially to involve the Meckel cavity, the cavernous sinus, and the foramen ovale tial damage that can be caused to surrounding nerves. Infl ammatory pseudotumors of the facial nerve have been surgically resected with subsequent restoration of facial nerve function; steroid therapy may be indicated for residual disease. 6, 10 Steroid therapy has also been successfully used to treat infl ammatory pseudotumors of the temporal bone, although high-dose steroid therapy is associated with a number of complications, including avascular necrosis of the hip, osteoporosis, and immunosuppression. 15, 24, 25 Because our patient's hip and leg pain might have heralded avascular necrosis, we reduced his prednisone dosage, which might have limited the drug's effi cacy. It has been reported that as many as 78% of all orbital infl ammatory pseudotumors can be initially treated successfully with steroid therapy alone, although subsequent recurrence rates have ranged from 25 to 52%, usually within 12 months after steroid treatment has been tapered or discontinued. 24, 26 Likewise, in patients with infl ammatory pseudotumors of the lung, steroid therapy has been shown to reduce tumor size or induce complete regression. 27 However, the results of steroid therapy are not as promising in patients with skull base tumors, as recurrences have been noted following discontinuation of the regimen. 13 Further research may help to standardize steroid dosing and duration for more effective treatment of temporal bone and skull base infl ammatory pseudotumors.
Radiotherapy has been used to treat (1) infl ammatory pseudotumors in anatomically inaccessible regions such as the skull base, (2) recurrent or refractory disease, (3) tumors that exhibit a poor response to steroid therapy, and (4) patients who cannot tolerate other treatments, although it is associated with radiation-induced neoplasms. 10, 13, 28, 29 Our patient's relatively young age and otherwise good health supported our decision to encourage steroid therapy rather than radiotherapy after the fi rst surgical excision. However, during his second recurrence, we detected no signifi cant mass, so we recommended radiotherapy. The responses of orbital infl ammatory pseudotumors to radiotherapy have been encouraging, with reported remission rates ranging from 66 to 100%. 13 One study of infl ammatory pseudotumors of the temporal bone showed a recurrence following a subtotal excision and radiotherapy, while another study did not. [30] [31] [32] In conclusion, infl ammatory pseudotumor rarely occurs in the temporal bone. Characteristic clinical and radiographic fi ndings distinguish this condition from mastoiditis, chronic otitis media, and cholesteatoma. An accurate diagnosis depends on a careful review of CT and MRI fi ndings and histopathologic analysis. These pseudotumors are locally destructive, and they have the capacity to erode through bone and invade soft-tissue structures, so they must be treated aggressively. Total surgical excision should be recommended as the initial treatment, with adjunctive therapy such as steroids and radiotherapy reserved for residual, recurrent, or inaccessible tumors.
